About ARAKODA® (tafenoquine) Tafenoquine is approved for malaria prophylaxis in the United States under the product name ARAKODA®. The safety of the approved regimen of tafenoquine for malaria ...

Tafenoquine is currently approved for malaria prophylaxis but has not yet been proven safe or effective for babesiosis. The study is supported by the U.S. Army Medical & Materiel Development Activity.

The main focus in this article is about cost–effectiveness of malaria patients in endemic areas treated therapeutically and using prophylaxis (IPT) when indicated. The cost–effectiveness with ...

Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA® and in Australia as KODATEF®. Both were commercially launched in 2019 and are currently distributed through ...

With malaria being one of the most significant causes of morbidity and mortality worldwide, prompt and effective treatment is essential to reduce the malaria burden. As there are several treatment ...

This strategy offers hope for reducing malaria in high-risk regions. Research: Transmission of transgenic mosquito-killing fungi during copulation. Image Credit: Kateryna Kon / Shutterstock In a ...

In Gambia, about 400 children in 1,000 died before their fifth birthday. Perhaps half the victims were killed by malaria. Professor Greenwood, now 86, a malaria expert at the London School of ...

Malaria is one of humanity’s oldest killers, with records of cases dating back to ancient Egypt. But despite efforts to eradicate the disease, a new report from the World Health Organization ...

Tafenoquine is currently FDA-approved for malaria prophylaxis but is not yet approved for babesiosis treatment. The press release states that tafenoquine has not been proven effective for the ...

Scientists from Oxford want to investigate a type of malaria that can remain dormant in the liver. Most of those infected have tested positive for malaria but other factors could still be at play.